S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Edwards Lifesciences (EW) Short Interest Ratio & Short Volume

$87.24
-2.81 (-3.12%)
(As of 04/17/2024 ET)

Edwards Lifesciences Short Interest Data

Current Short Volume
10,380,000 shares
Previous Short Volume
10,450,000 shares
Change Vs. Previous Month
-0.67%
Dollar Volume Sold Short
$991.91 million
Short Interest Ratio / Days to Cover
2.6
Last Record Date
March 31, 2024
Outstanding Shares
601,930,000 shares
Float Size
591,800,000 shares
Short Percent of Float
1.75%
Today's Trading Volume
2,877,656 shares
Average Trading Volume
3,875,281 shares
Today's Volume Vs. Average
74%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Edwards Lifesciences ?

Sign up to receive the latest short interest report for Edwards Lifesciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EW Short Interest Over Time

EW Days to Cover Over Time

EW Percentage of Float Shorted Over Time

Edwards Lifesciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202410,380,000 shares $991.91 million -0.7%1.8%2.6 $95.56
3/15/202410,450,000 shares $964.64 million +23.8%1.8%2.7 $92.31
2/29/20248,440,000 shares $716.30 million -16.4%1.4%1.9 $84.87
2/15/202410,090,000 shares $868.35 million +1.3%1.7%2.3 $86.06
1/31/20249,960,000 shares $781.56 million -8.4%1.7%2.2 $78.47
1/15/202410,870,000 shares $804.71 million +2.0%1.8%2.4 $74.03
12/31/202310,660,000 shares $812.83 million -21.3%1.8%2.3 $76.25
12/15/202313,540,000 shares $1.04 billion +34.7%2.3%2.8 $76.90
11/30/202310,050,000 shares $680.49 million -6.5%1.7%2.3 $67.71
11/15/202310,750,000 shares $720.36 million -6.3%1.8%2.6 $67.01
10/31/202311,470,000 shares $730.87 million -1.1%1.9%2.9 $63.72
10/15/202311,600,000 shares $821.05 million -13.4%1.9%3.1 $70.78
9/30/202313,400,000 shares $928.35 million +5.5%2.2%3.8 $69.28
9/15/202312,700,000 shares $929.64 million +18.1%2.1%4 $73.20
8/31/202310,750,000 shares $822.05 million +13.0%1.8%3.4 $76.47
8/15/20239,510,000 shares $759.47 million +0.4%1.6%3 $79.86
7/31/20239,470,000 shares $777.20 million -2.9%1.6%3.3 $82.07
7/15/20239,750,000 shares $910.46 million -0.9%1.6%3.7 $93.38
6/30/20239,840,000 shares $928.21 million -4.4%1.6%3.7 $94.33
6/15/202310,290,000 shares $939.37 million -7.4%1.7%3.8 $91.29
5/31/202311,110,000 shares $935.91 million +12.9%1.9%3.9 $84.24
5/15/20239,840,000 shares $874.97 million +7.2%1.6%3.2 $88.92
4/30/20239,180,000 shares $807.66 million -27.3%1.5%2.8 $87.98
4/15/202312,620,000 shares $1.06 billion -10.1%2.1%3.6 $84.36
3/31/202314,040,000 shares $1.16 billion -17.1%2.3%4.1 $82.73
3/15/202316,940,000 shares $1.35 billion +32.7%2.8%4.7 $79.48
2/28/202312,770,000 shares $1.03 billion +6.8%2.1%3.2 $80.44
2/15/202311,960,000 shares $931.92 million -12.4%2.0%3 $77.92
1/31/202313,650,000 shares $1.05 billion -2.0%2.2%3 $76.70
1/15/202313,930,000 shares $1.09 billion -9.2%2.3%2.7 $78.31
12/30/202215,340,000 shares $1.14 billion +9.9%2.5%3 $74.61
12/15/202213,960,000 shares $1.03 billion +27.0%2.3%2.8 $73.55
11/30/202210,990,000 shares $848.98 million +4.0%1.8%2.3 $77.25
11/15/202210,570,000 shares $802.90 million +30.3%1.7%2.5 $75.96
10/31/20228,110,000 shares $587.41 million +8.9%1.3%2.2 $72.43
10/15/20227,450,000 shares $614.03 million -1.7%1.2%2.7 $82.42
9/30/20227,580,000 shares $626.34 million +15.9%1.2%3 $82.63
9/15/20226,540,000 shares $620.52 million +77.7%1.1%2.5 $94.88
8/31/20223,680,000 shares $331.57 million -27.0%0.6%1.4 $90.10
8/15/20225,040,000 shares $527.89 million -9.0%0.8%2 $104.74
Forget Nvidia, buy this A.I. Stock Now (Ad)

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

Click here to see the details.

EW Short Interest - Frequently Asked Questions

What is Edwards Lifesciences' current short interest?

Short interest is the volume of Edwards Lifesciences shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 10,380,000 shares of EW short. 1.75% of Edwards Lifesciences' shares are currently sold short. Learn More on Edwards Lifesciences' current short interest.

What is a good short interest ratio for Edwards Lifesciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EW shares currently have a short interest ratio of 3.0. Learn More on Edwards Lifesciences's short interest ratio.

Which institutional investors are shorting Edwards Lifesciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Edwards Lifesciences: Wealth Enhancement Advisory Services LLC, IMC Chicago LLC, GTS Securities LLC, Wolverine Trading LLC, Paloma Partners Management Co, Caas Capital Management LP, Citadel Advisors LLC, Point72 Asset Management L.P., Cubist Systematic Strategies LLC, Capital Fund Management S.A., PEAK6 Investments LLC, Pura Vida Investments LLC, Capstone Investment Advisors LLC, Allianz Asset Management GmbH, IMC Chicago LLC, Concourse Financial Group Securities Inc., Genus Capital Management Inc., Simplex Trading LLC, and SpiderRock Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Edwards Lifesciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.75% of Edwards Lifesciences' floating shares are currently sold short.

Is Edwards Lifesciences' short interest increasing or decreasing?

Edwards Lifesciences saw a decline in short interest in March. As of March 31st, there was short interest totaling 10,380,000 shares, a decline of 0.7% from the previous total of 10,450,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Edwards Lifesciences' float size?

Edwards Lifesciences currently has issued a total of 601,930,000 shares. Some of Edwards Lifesciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edwards Lifesciences currently has a public float of 591,800,000 shares.

How does Edwards Lifesciences' short interest compare to its competitors?

1.75% of Edwards Lifesciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Edwards Lifesciences: STERIS plc (2.72%), Intuitive Surgical, Inc. (0.96%), Zimmer Biomet Holdings, Inc. (2.31%), Align Technology, Inc. (2.01%), DexCom, Inc. (3.78%), Cencora, Inc. (4.70%), Takeda Pharmaceutical Company Limited (0.26%), Becton, Dickinson and Company (1.02%), IQVIA Holdings Inc. (1.61%), IDEXX Laboratories, Inc. (2.14%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Edwards Lifesciences stock?

Short selling EW is an investing strategy that aims to generate trading profit from Edwards Lifesciences as its price is falling. EW shares are trading down $2.81 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Edwards Lifesciences?

A short squeeze for Edwards Lifesciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EW, which in turn drives the price of the stock up even further.

How often is Edwards Lifesciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EW, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NYSE:EW) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners